Characterization of a monoclonal antibody reactive with a subset of human breast tumors

D. Yuan, F. J. Hendler, E. S. Vitetta

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Fusion of spleen cells, from mice immunized against the human hormone-dependent breast cancer cell line ZR-75-1, with mu­ rine myeloma cells resulted in the establishment of a hybridoma cell line, HY59-H10 (H59). The purified monoclonal IgM produced by the hybridoma reacts with the most differentiated human breast tumor cell lines but not with cells derived from normal breast secretions or with numerous other malignant cell lines. Of 106 biopsy specimens exam­ ined, H59 bound to 54% of malignant breast specimens, to 83% of fibroadenomas, and to 82% of specimens containing fibrocystic dis­ ease. Binding could not be detected in uninvolved breast tissue.

Original languageEnglish (US)
Pages (from-to)719-728
Number of pages10
JournalJournal of the National Cancer Institute
Volume68
Issue number5
DOIs
StatePublished - May 1982

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Characterization of a monoclonal antibody reactive with a subset of human breast tumors'. Together they form a unique fingerprint.

  • Cite this